Annual CFO
-$7.24 M
-$3.36 M-86.79%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual cash flow from operations is -$7.24 million, with the most recent change of -$3.36 million (-86.79%) on December 31, 2023.
- During the last 3 years, COEP annual CFO has fallen by -$4.10 million (-130.84%).
- COEP annual CFO is now -130.84% below its all-time high of -$3.14 million, reached on December 1, 2020.
Performance
COEP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.89 M
-$474.90 K-33.50%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly cash flow from operations is -$1.89 million, with the most recent change of -$474.90 thousand (-33.50%) on September 1, 2024.
- Over the past year, COEP quarterly CFO has dropped by -$198.80 thousand (-11.74%).
- COEP quarterly CFO is now -7700.80% below its all-time high of $24.90 thousand, reached on June 1, 2021.
Performance
COEP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$6.91 M
+$65.80 K+0.94%
September 1, 2024
Summary
- As of February 8, 2025, COEP TTM cash flow from operations is -$6.91 million, with the most recent change of +$65.80 thousand (+0.94%) on September 1, 2024.
- Over the past year, COEP TTM CFO has increased by +$333.10 thousand (+4.60%).
- COEP TTM CFO is now -995.57% below its all-time high of -$630.40 thousand, reached on June 1, 2021.
Performance
COEP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
COEP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.8% | -11.7% | +4.6% |
| 3 y3 years | -130.8% | -83.1% | -18.0% |
| 5 y5 years | -130.8% | -83.1% | -18.0% |
COEP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.8% | at low | -806.0% | +3.4% | -113.3% | +7.4% |
| 5 y | 5-year | -130.8% | at low | -7700.8% | +48.1% | -995.6% | +7.4% |
| alltime | all time | -130.8% | at low | -7700.8% | +48.1% | -995.6% | +7.4% |
Coeptis Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.89 M(+33.5%) | -$6.91 M(-0.9%) |
| Jun 2024 | - | -$1.42 M(-25.5%) | -$6.97 M(-6.5%) |
| Mar 2024 | - | -$1.90 M(+12.3%) | -$7.46 M(+3.0%) |
| Dec 2023 | -$7.24 M(+86.8%) | -$1.69 M(-13.5%) | -$7.24 M(+13.2%) |
| Sep 2023 | - | -$1.96 M(+2.9%) | -$6.39 M(+16.9%) |
| Jun 2023 | - | -$1.90 M(+13.0%) | -$5.47 M(+18.9%) |
| Mar 2023 | - | -$1.68 M(+98.8%) | -$4.60 M(+18.6%) |
| Dec 2022 | -$3.88 M | -$847.40 K(-18.0%) | -$3.88 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.03 M(-0.0%) | -$3.24 M(-44.7%) |
| Jun 2022 | - | -$1.03 M(+7.5%) | -$5.85 M(+22.1%) |
| Mar 2022 | - | -$961.70 K(+360.4%) | -$4.80 M(+6.8%) |
| Dec 2021 | -$4.49 M(+43.2%) | - | - |
| Dec 2021 | - | -$208.90 K(-94.3%) | -$4.49 M(+4.9%) |
| Sep 2021 | - | -$3.65 M(<-9900.0%) | -$4.28 M(+579.0%) |
| Jun 2021 | - | $24.90 K(-103.8%) | -$630.40 K(-3.8%) |
| Mar 2021 | - | -$655.30 K | -$655.30 K |
| Dec 2020 | -$3.14 M | - | - |
FAQ
- What is Coeptis Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual CFO year-on-year change?
- What is Coeptis Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly CFO year-on-year change?
- What is Coeptis Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Coeptis Therapeutics?
- What is Coeptis Therapeutics TTM CFO year-on-year change?
What is Coeptis Therapeutics annual cash flow from operations?
The current annual CFO of COEP is -$7.24 M
What is the all time high annual CFO for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual cash flow from operations is -$3.14 M
What is Coeptis Therapeutics annual CFO year-on-year change?
Over the past year, COEP annual cash flow from operations has changed by -$3.36 M (-86.79%)
What is Coeptis Therapeutics quarterly cash flow from operations?
The current quarterly CFO of COEP is -$1.89 M
What is the all time high quarterly CFO for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly cash flow from operations is $24.90 K
What is Coeptis Therapeutics quarterly CFO year-on-year change?
Over the past year, COEP quarterly cash flow from operations has changed by -$198.80 K (-11.74%)
What is Coeptis Therapeutics TTM cash flow from operations?
The current TTM CFO of COEP is -$6.91 M
What is the all time high TTM CFO for Coeptis Therapeutics?
Coeptis Therapeutics all-time high TTM cash flow from operations is -$630.40 K
What is Coeptis Therapeutics TTM CFO year-on-year change?
Over the past year, COEP TTM cash flow from operations has changed by +$333.10 K (+4.60%)